13F Data
Security · CUSIP 803607AD2

SAREPTA THERAPEUTICS INC

NOTE 1.250% 9/1 · institutional ownership from 13F filings
13F holders
5
Shares held
1.6M
Value held
$1.6M
New / sold out
1 / 2
Added / reduced
2 / 0
net -3.5M shares

13F holders by quarter

Q3 2023: 8Q4 2023: 6Q1 2024: 7Q2 2024: 12Q3 2024: 10Q4 2024: 10Q1 2025: 12Q2 2025: 7Q3 2025: 5Q4 2025: 4Q1 2026: 6Q2 2026: 5Q3 2026: 6
Q3 2023Q3 2026

Net shares bought by existing holders

Q3 2023: 18.0MQ4 2023: -2.2MQ1 2024: 5.7MQ2 2024: 21.0MQ3 2024: -13.7MQ4 2024: -7.1MQ1 2025: -715.8KQ2 2025: -6.1MQ3 2025: 996.5KQ4 2025: -4.4MQ1 2026: -2.4MQ2 2026: -3.5MQ3 2026: 132.0K
Q3 2023Q3 2026

Top holders · Q2 2026

ManagerSharesValue% of portfolio
FINANCIAL CONSULATE, INC1,047,000$990.9K0.11%
HB Wealth Management, LLC555,000$523.2K0.00%
Cambridge Investment Research Advisors, Inc.26,000$24.0K0.00%
Greenspring Advisors, LLC14,000$13.3K0.00%
ROTHSCHILD INVESTMENT LLC1,000$9430.00%

Biggest buyers

ManagerChangeShares changeChange %
FINANCIAL CONSULATE, INCAdded+48,000+4.8%
Greenspring Advisors, LLCNew+14,000–
Cambridge Investment Research Advisors, Inc.Added+13,000+100.0%

Biggest sellers

ManagerChangeShares changeChange %
BNP PARIBAS ASSET MANAGEMENT Holding S.A.Sold out-3,500,000-100.0%
Wealthspire Advisors, LLCSold out-27,000-100.0%